DOI : 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue S 1 · Volume 115 · 2007 DOI: 10.1055/s-002-5619


51. Annual Meeting of the German Society of Endocrinology (DGE)
Salzburg, 7-10 March 2007

Congress-President of the DGE: Prof. Dr. med. Michael Buchfelder, Erlangen-Nürnberg; Congress-President of the ÖGES: Prof. Dr. med. Anton Luger, Wien
Abstracts (HTML) List of Authors
  • P01_052
    Nüsken, K. D.; Petrasch, M.; Rauh, M.; Stöhr, W.; Nüsken, E.; Schneider, H.; Dötsch, J.:

    Reduced plasma visfatin in end-stage renal disease is associated with reduced body fat mass and elevated serum insulin

  • P01_053
    Höfle, G.; Saely, C. H.; Risch, L.; Rein, P.; Koch, L.; Schmid, F.; Aczél, S.; Marte, T.; Langer, P.; Drexel, H.:

    Leptin, leptin soluble receptor and coronary atherosclerosis

  • P01_054
    Schinner, S.; Ülgen, F.; Schott, M.; Scherbaum, W. A.:

    Adipocytes induce insulin secretion and glucokinase gene transcription in pancreatic beta-cells through the Wnt-signalling pathway

  • P01_055
    Garten, A.; Körner, A.; Tauscher, R.; Berthold, A.; Kratzsch, J.; Kiess, W.:

    Visfatin – an activator of the insulin signalling pathway?

  • P01_056
    Höfle, G.; Saely, C. H.; Risch, L.; Koch, L.; Schmid, F.; Aczél, S.; Berchtold, S.; Marte, T.; Drexel, H.:

    Impact of resistin on the incidence of vascular events in patients undergoing coronary angiography

  • P01_057
    Körner, A.; Kratzsch, J.; Garten, A.; Blüher, M.; Kiess, W.:

    The tale of visfatin – or: About knowing what to measure ..

  • P01_058
    Möhlig, M.; Ghadamgahi, E.; Weickert, M. O.; Arafat, A. M.; Spranger, J.; Pfeiffer, A. F. H.; Schöfl, C.:

    FABP-A correlates with body fat mass in PCOS women

  • P01_059
    Vleugels, K.; Schinner, S.; Buro, U.; Sperber, S.; Bornstein, S. R.; Ehrhart-Bornstein, M.; Krug, A. W.:

    Adipocyte-induced ERK1/2-mediated StAR activation enhances aldosterone secretion and sensitizes human adrenocortical cells to AngII

  • P01_060
    Göncz, E.; Grötzinger, C.; Mergler, S.; El-Zayat, B. F.; Theodoropoulou, M.; Stalla, G. K.; Wiedenmann, B.; Strowski, M. Z.; Plöckinger, U.:

    Orexin-A inhibits glucagon secretion and gene expression by Foxo1 dependent pathway

  • P01_061
    Wellhöner, P.; Klages, A.; Sayk, F.; Dodt, C.:

    Effect of intranasally administered MSH/ACTH 4–10 on skeletal muscle and adipose tissue metabolism in young men

  • P01_062
    Bollheimer, L. C.; Wobser, H.; Wrede, C. E.; Schäffler, A.; Schölmerich, J.; Büchler, C.; Buettner, R.:

    Glucagon under high fat diet induced obesity

  • P01_063
    Körner, A.; Kovacs, P.; Berndt, J.; Stumvoll, M.; Kiess, W.:

    TCF7L2-gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children

  • P01_064
    Fischer-Posovszky, P.; Kukulus, V.; Killian, A.; Debatin, K. M.; Wabitsch, M.:

    Effects of resveratrol on human adipocyte biology

  • P01_065
    Wiegand, S.; Richardt, A.; Remer, T.; Wudy, S. A.; Tomlinson, J. W.; Grüters, A.; Stewart, P. M.; Strasburger, C. J.; Quinkler, M.:

    11beta-hydroxysteroid dehydrogenase type 1 in obese children